|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Net income from held-for-sale assets | |||||
| Net income from discontinued operations, net of taxes | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Loss on disposal of property and equipment | |||||
| Impairment of operating lease right-of-use assets | |||||
| Depreciation of property and equipment | |||||
| Amortization of intangible assets | |||||
| Goodwill, intangible and other asset impairment | |||||
| Stock-based compensation expense related to employee and director stock awards | |||||
| Total stock-based compensation expense related to employee and director stock awards | |||||
| Non-cash loss on divestiture of subsidiary | |||||
| Non-cash loss on extinguishment of Secured Convertible Note | |||||
| Non-cash expense incurred to obtain consent of Secured Convertible Note holders | |||||
| Non-cash loss (gain) on changes in fair value of warrant liability | |||||
| Total non-cash loss (gain) on changes in fair value of warrant liability | |||||
| Interest expense related to amortization of debt issuance and debt discount | |||||
| Non-cash loss on changes in fair value of embedded derivative liability | |||||
| Non-cash gain on changes in fair value of contingent liability | |||||
| Non-cash loss on modification of common stock warrants | |||||
| Non-cash loss on modification of warrants | |||||
| Non-cash right-of-use amortization | |||||
| Impairment of long-lived assets | |||||
| Amortization of debt discounts on convertible notes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities, continuing operations | |||||
| Proceeds from divestiture of subsidiary | |||||
| Purchases of property and equipment | |||||
| Net cash provided by (used in) investing activities, continuing operations | |||||
| Net cash used in operating activities, continuing operations | |||||
| Financing activities: | |||||
| Cash payment pursuant to warrant exchange | |||||
| Proceeds from Warrants Exercise | |||||
| Warrants and Pre-funded Warrants | |||||
| Total proceeds from Warrants Exercise | |||||
| Payment on line of credit | |||||
| Proceeds from issuance of October 2025 pre-funded warrants | |||||
| Proceeds from issuance of common stock and pre-funded warrants the 2024 Public Offering, net of issuance costs | |||||
| Proceeds from Bridge Loan | |||||
| Proceeds from issuance of Secured Convertible Notes and May 2023 Warrants, net of discounts | |||||
| Payment on Bridge Note | |||||
| Payments on Secured Convertible Notes | |||||
| Payment on redemption of Series F Preferred Stock | |||||
| Dividend paid | |||||
| Cash debt issuance cost | |||||
| Proceeds from issuance of Series C Preferred Stock and November 2022 Warrants, net | |||||
| Net cash provided by financing activities, continuing operations | |||||
| Net decrease in cash, cash equivalents, and restricted cash, continuing operations | |||||
| Net increase in cash and cash equivalents, held-for-sale assets | |||||
| Net increase in cash and cash equivalents, discontinued operations | |||||
| Net decrease in cash, cash equivalents and restricted cash, consolidated | |||||
| us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash of continuing operations, end of year | |||||
| us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | |||||
| Interest paid in continuing operations | |||||
| Income taxes paid | |||||
| Interest paid in discontinued operations | |||||
| Conversions of preferred stock to common stock | |||||
| Conversion of Series B Preferred Stock to Common Stock | |||||
| Total conversions of preferred stock to common stock | |||||
| Down round feature adjustments related to preferred stock | |||||
| Equity transferred to warrant liabilities | |||||
| Common stock warrant modification recorded as debt discount | |||||
| Down round feature adjustments related to common stock warrants | |||||
| Issuance of derivative liability in conjunction with Unsecured Convertible Notes | |||||
| Warrant liabilities transferred to equity | |||||
| Warrant Liability | |||||
| Total warrant liabilities transferred to equity | |||||
| Addition of operating lease, right-of-use asset | |||||
Loading...